Research Article| Volume 17, ISSUE 4, P667-679, July 1995

Download started.


Efficacy of long-term treatment with nipradilol, a nitroester-containing beta-blocker, in patients with mild-to-moderate essential hypertension

      This paper is only available as a PDF. To read, Please Download here.


      The effects of long-term treatment with nipradilol, a nitroester-containing beta-blocker, on casual and 24-hour blood pressures were studied in 70 patients with mild-to-moderate essential hypertension. Antihypertensive effects of nipradilol on casual blood pressure were observed in 68% of patients. Nipradilol reduced pulse rates, but no bradycardia was observed. The usefulness of nipradilol in the present study was 65%. The results of ambulatory blood pressure monitoring indicated that nipradilol reduced systolic blood pressure more than diastolic blood pressure, and reduced blood pressure during waking more than during sleep. These results suggest that nipradilol is a safe and useful long-term antihypertensive drug in both young and older patients with mild-to-moderate essential hypertension. When administered twice daily, nipradilol is effective throughout a 24-hour period.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Clinical Therapeutics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V).
        Arch Intern Med. 1993; 153: 154-183
      2. 1993 Guidelines for the Management of Mild Hypertension: Memorandum from a WHO/ISH meeting.
        Bull Who. 1993; 71: 503-517
        • Jydtin H
        • Kusus T
        • Daniel W
        • et al.
        Propranolol therapy in essential hypertension.
        Am Heart J. 1972; 83: 589-595
        • Tarazi RC
        • Dustan HP
        Beta-adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations.
        Am J Cardiol. 1972; 29: 633-640
        • Uchida T
        • Nakamura M
        • Shimizu S
        • et al.
        Vasoactive and beta-adrenoceptor blocking properties of 3,4-hydro-8(2-hydroxy-3-isopropylamino-propoxy)3-nitroxy-2H-1-benzopyran (K-351), a new antihypertensive agent.
        Arch Int Pharmacodyn Ther. 1983; 262: 132-149
        • Haneda T
        • Ichihara K
        • Onodera S
        Effects of nicorandil and nipradilol on ischemic myocardium in perfused rat heart.
        Eur J Pharmacol. 1989; 162: 81-87
        • Mancia G
        Ambulatory blood pressure monitoring: Research and clinical applications.
        J Hypertens. 1990; 8 (Suppl 7): S1-S13
        • White WB
        • Pickering TG
        • Morganroth J
        • et al.
        A multicenter evaluation of the A&D TM-2420 ambulatory blood pressure recorder.
        Am J Hypertens. 1991; 4: 890-896
        • Kaneko Y
        • Shionoiri H
        • Limura K
        • et al.
        Hypotensive effect and safety of chronic administration of nipradilol (K-351) in essential hypertension.
        Ther Res. 1986; 5: 135-154
        • Rion F
        • Waeber B
        • Graf HJ
        • et al.
        Blood pressure response to antihypertensive therapy. Ambulatory versus office blood pressure readings.
        J Hypertens. 1985; 3: 139-143
        • Berglund G
        • De Faire U
        • Castenfors J
        • et al.
        Monitoring 24-hour blood pressure in a drug trial. Evaluation of a noninvasive device.
        Hypertension. 1985; 7: 688-694
        • Sirgo MA
        • Mills RJ
        • DeQuattro V
        Effects of antihypertensive agents on circadian blood pressure and heart rate patterns.
        Arch Intern Med. 1988; 148: 2547-2552
        • Floras JS
        • Jones JV
        • Hassan MO
        • et al.
        Ambulatory blood pressure during once-daily randomised, double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
        BMJ. 1982; 285: 1387-1392
        • Raftery EB
        • Carrageta MO
        Hypertension and beta blockers. Are they all the same?.
        Int J Cardiol. 1985; 7: 337-346
        • Nakanishi T
        • Nishimura M
        • Kubota S
        • et al.
        Effects of nipradilol on 24-hour blood pressure in patients with essential hypertension.
        Curr Ther Res. 1990; 48: 198-205